ALDH2 and Hyperglycemia: Alda-1, a specific activator of ALDH2, can significantly reduce ALDH2-O-GlcNAcylation to improve I/R combined with hyperglycemia-induced infarct size, the cell apoptosis index and cardiac dysfunction [160].